Camber Capital Management as of March 31, 2011
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 38 positions in its portfolio as reported in the March 2011 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 12.6 | $99M | 750k | 132.59 | |
| CVS Caremark Corporation (CVS) | 8.3 | $65M | 1.9M | 34.32 | |
| Sanofi-Aventis SA (SNY) | 6.0 | $48M | 1.4M | 35.22 | |
| Humana (HUM) | 5.3 | $42M | 600k | 69.94 | |
| CareFusion Corporation | 5.1 | $40M | 1.4M | 28.20 | |
| Community Health Systems (CYH) | 5.1 | $40M | 1.0M | 39.99 | |
| Eli Lilly & Co. (LLY) | 4.5 | $35M | 1.0M | 35.17 | |
| LifePoint Hospitals | 3.8 | $30M | 751k | 40.18 | |
| Tenet Healthcare Corporation | 3.8 | $30M | 4.0M | 7.45 | |
| Acorda Therapeutics | 3.7 | $29M | 1.3M | 23.20 | |
| Medco Health Solutions | 3.6 | $28M | 500k | 56.16 | |
| Elan Corporation | 3.5 | $28M | 4.0M | 6.88 | |
| Universal American Corporation | 3.5 | $27M | 1.2M | 22.91 | |
| Health Management Associates | 3.4 | $27M | 2.5M | 10.90 | |
| Wright Medical | 3.1 | $24M | 1.4M | 17.01 | |
| Regeneron Pharmaceuticals (REGN) | 2.9 | $23M | 500k | 44.94 | |
| Conceptus | 2.8 | $22M | 1.5M | 14.45 | |
| Auxilium Pharmaceuticals | 2.4 | $19M | 887k | 21.47 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.1 | $17M | 350k | 47.93 | |
| ArthroCare Corporation | 2.1 | $17M | 502k | 33.34 | |
| AngioDynamics (ANGO) | 2.0 | $16M | 1.0M | 15.12 | |
| St. Jude Medical | 1.9 | $15M | 300k | 51.26 | |
| Cardionet | 1.4 | $11M | 2.3M | 4.79 | |
| SonoSite | 1.4 | $11M | 326k | 33.32 | |
| AMAG Pharmaceuticals | 1.2 | $9.3M | 554k | 16.70 | |
| Targacept | 0.8 | $6.7M | 253k | 26.59 | |
| Rite Aid Corporation | 0.8 | $6.4M | 6.1M | 1.06 | |
| Savient Pharmaceuticals | 0.7 | $5.3M | 500k | 10.60 | |
| Dynavax Technologies Corporation | 0.6 | $5.0M | 1.8M | 2.76 | |
| Dynavax Technologies Corporation | 0.3 | $2.5M | 1.7M | 1.42 | |
| Celgene Corp right 12/31/2011 | 0.3 | $2.4M | 949k | 2.50 | |
| WorldHeart Corporation (WHRT) | 0.3 | $2.1M | 1.6M | 1.28 | |
| Omnicell (OMCL) | 0.2 | $1.7M | 113k | 15.24 | |
| Anthera Pharmaceuticals | 0.2 | $1.6M | 400k | 3.95 | |
| Alnylam Pharmaceuticals (ALNY) | 0.1 | $1.0M | 106k | 9.57 | |
| Dyax | 0.1 | $736k | 457k | 1.61 | |
| WorldHeart Corporation (WHRT) | 0.0 | $164k | 1.6M | 0.10 | |
| ViroPharma Incorporated | 0.0 | $36M | 1.9M | 18.62 |
